semaglutide starting dose for weight loss dosing guidelines 2026 Semaglutide Weight Loss Program |

Hogg E, Athreya K, Basile C, Tan EE, Kaminski J, Tagliati M

And then came the cold shower

Quick Answer: GLP-1 receptor agonists are not licensed or supported by clinical evidence for rheumatoid arthritis treatment in the UK, and microdosing remains experimental without established safety or efficacy data

To maximise GLP-1 results, medicines should be combined with healthy eating, regular physical activity, and behaviour changes

Long-term follow-up studies show that people who maintain GLP-1 therapy keep weight off, while those who discontinue gradually regainnot because the drug was a quick fix, but because the underlying appetite dysregulation returns

As a result, they stick together like sheets of tissue paper that peel off over the course of healing